Related Experiment Video
Updated: Dec 6, 2025

A Retrospective Study on Endoscopic Surgery for the Treatment of Paravertebral Abscess in Spinal Tuberculosis Patients
Published on: October 25, 2024
Successful management with bisphosphonate treatment in a child with tuberculosis-associated hypercalcemia
Suna Kilinc1, Ozlem Bostan2, Meltem Erol2
1Department of Pediatric Endocrinology, Istanbul Bagcilar Training and Research Hospital, Istanbul, Turkey.
Insights
Severe hypercalcemia in children, though rare, can stem from granulomatous diseases like tuberculosis. This case highlights successful bisphosphonate treatment for hypercalcemia caused by miliary tuberculosis.
Area of Science:
- Pediatric Endocrinology
- Infectious Diseases
- Metabolic Disorders
Background:
- Hypercalcemia is a frequent metabolic issue in children, typically caused by hyperparathyroidism, vitamin D toxicity, genetic conditions, or malignancies.
- Granulomatous diseases are an uncommon etiology for pediatric hypercalcemia, often presenting mildly or asymptomatically.
Observation:
- This report details a pediatric case of severe hypercalcemia.
- The patient's condition was linked to miliary tuberculosis, a granulomatous disease.
Findings:
- The primary mechanism identified for hypercalcemia in this tuberculosis case was elevated synthesis of 1,25(OH)2D3 by activated macrophages within granuloma tissue.
- Successful management of severe hypercalcemia was achieved using bisphosphonate therapy.
Implications:
- This case underscores the importance of considering granulomatous diseases, particularly tuberculosis, in the differential diagnosis of pediatric hypercalcemia.
- Bisphosphonates represent an effective therapeutic option for managing severe hypercalcemia associated with miliary tuberculosis in children.
Abstract:
Hypercalcemia is a common metabolic abnormality in children and generally occurs due to hyperparathyroidism, vitamin D toxicity, some genetic disorders and malignant diseases. Granulomatous diseases are a rare cause of hypercalcemia in children, which are usually mild and asymptomatic. Severe hypercalcemia in granulomatous diseases has also been reported in the literature. Here, we report a child presenting with severe hypercalcemia secondary to miliary tuberculosis with successful management with bisphosphonate treatment. Increased 1,25(OH)2D3 synthesis by activated macrophages in the granuloma tissue is the major mechanism of hypercalcemia in tuberculosis.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Urinary Tract Calculi III: Medical Management
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Urinary Tract Calculi V: Nursing Management
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
